This Medical Stock Has Been Hammered — Here’s The Trade

This Medical Stock Has Been Hammered — Here’s The Trade

Late last month, Align Technology (NASDAQ:ALGN) was hammered lower after reporting earnings that disappointed the street. The stock actually peaked out in September 2018 at $398.87 a share. It then made a lower high on the daily chart on May 15, 2019 at $334.64 a share.

Currently, the stock is trading at $176.00 a share, but it remains in a weak technical position on the charts. The stock is now trading below its 200-week moving average which is a near term negative for the stock price. While the stock is currently oversold it is still signaling further downside before a solid bottom is formed. The one level that has caught my eye in the stock is around the $138.00 area. This level is where the stock actually broke out in May 2017. As you all know by now, I really like pullbacks into past break-out levels as institutions will generally support the equity around this area. Please note, ALGN stock generally trades less than 1 million shares a day, so it is always vulnerable to overshoot levels.

This Medical Stock Has Been Hammered — Here’s The Trade

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.